产品
编 号：F745188
产品类型
规格
价格
是否有货
结构图
CAS No: 1438851-35-4
产品详情
生物活性：
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research.
体外研究：
ABP 215 (Bevacizumab-awwb) 与 VEGF-A 结合，阻止 VEGF-A 与内皮细胞表面的 VEGF 受体结合，抑制内皮细胞增殖和新血管形成，从而导致肿瘤脉管系统正常化。
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research.
体外研究：
ABP 215 (Bevacizumab-awwb) 与 VEGF-A 结合，阻止 VEGF-A 与内皮细胞表面的 VEGF 受体结合，抑制内皮细胞增殖和新血管形成，从而导致肿瘤脉管系统正常化。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备